CD8A and melanoma: Indeed, tumor progression was not associated with evolution toward T-cell exhaustion or other kind of CD8+ T-cell hyporesponsiveness states, but rather with loss of antigen presentation, a common escape mechanism of melanoma tumor cells to immunotherapy52 as well as with activation of counteracting CD4+ T-cell-mediated regulatory mechanisms, likely regulatory T cell, in the TME.